Dark
Light
System
Institutional Investment Manager
Alyeska Investment Group, L.P.
Alyeska Investment Group, L.P. (CIK: 0001453072) incorporated in Delaware, located at 77 West Wacker Drive, Chicago, IL. Institutional holdings reported to the SEC.

Institutional Holdings (2014Q3)
Portfolio Summary: 378 holdings with a total value of $4,863,778,000.
#
Name
Shares
Value ($)
%
Options
Notes
301 ARDMORE SHIPPING CORP COM 157,754 1,720,000 0.04%
302 TESARO INCORPORATED 62,950 1,695,000 0.03%
303 MEDLEY MGMT INC 100,000 1,687,000 0.03%
304 SPORTSMANS WAREHOUSE 250,000 1,684,000 0.03%
305 CASTLIGHT HEALTH INC COM CL B 119,987 1,553,000 0.03%
306 INTL RECTIFIER COR 35,650 1,399,000 0.03%
307 Inventure Foods Inc 107,693 1,396,000 0.03%
308 VITAE PHARMACEUTICALS INC 182,609 1,393,000 0.03%
309 FIVE OAKS INVT CORPORATION REIT 131,190 1,377,000 0.03%
310 COMMSCOPE HLDG COMPANY INCORPORATED 56,100 1,341,000 0.03%
311 QLIK TECHNOLOGIES INC COM 49,128 1,328,000 0.03%
312 CONCERT PHARMACEUTICALS INCORPORATED 102,280 1,290,000 0.03%
313 IDREAMSKY TECHNOLOGY LIMITED 75,000 1,276,000 0.03%
314 AK STL HLDG CORP 150,000 1,202,000 0.02%
315 USA Compression Partners, LP 48,853 1,187,000 0.02%
316 AMPHASTAR PHARMACEUTICALS IN COM 98,974 1,153,000 0.02%
317 MOBILEIRON INC COM NEW 101,950 1,136,000 0.02%
318 PARNELL PHARMACEUTICALS HOLDINGS LTD 197,346 1,135,000 0.02%
319 QLOGIC CORP 123,686 1,133,000 0.02%
320 GALENA BIOPHARMA INC 530,000 1,092,000 0.02% Call
321 ARATANA THERAPEUTICS INC 105,500 1,059,000 0.02%
322 HERON THERAPEUTICS INC COM 125,669 1,047,000 0.02%
323 BIOAMBER INC 103,951 1,037,000 0.02% Call
324 SYNAGEVA BIOPHARMA CORP 15,000 1,032,000 0.02%
325 CARROLS RESTAURANT GROUP INC 141,403 1,005,000 0.02%
326 ARDELYX INC COM 70,633 1,004,000 0.02%
327 FOAMIX PHARMACEUTICALS LTD 182,609 995,000 0.02%
328 MAST THERAPEUTICS INC COM 1,775,000 989,000 0.02% Call
329 ZHAOPIN LTD 75,000 973,000 0.02%
330 TREVENA INC 150,266 965,000 0.02%
331 ZS PHARMA INC 23,930 939,000 0.02%
332 KYTHERA BIOPHARMACEUTICALS I 28,342 928,000 0.02%
333 VITESSE SEMICONDUCTOR CORP 250,000 900,000 0.02%
334 Innocoll 136,422 900,000 0.02%
335 AUSPEX PHARMACEUTICALS INC 34,856 895,000 0.02%
336 DICERNA PHARMACEUTICALS INC 68,406 871,000 0.02%
337 SUPERNUS PHARMACEUTICALS INC 99,547 865,000 0.02%
338 IMMUNE DESIGN CORP 46,833 827,000 0.02%
339 INTRA-CELLULAR THERAPIES INC 59,995 823,000 0.02%
340 OPOWER INC 43,144 814,000 0.02%
341 LOMBARD MEDICAL INC 104,109 801,000 0.02%
342 ARGOS THERAPEUTICS INC 79,430 799,000 0.02%
343 IMPRIVATA INC 50,000 776,000 0.02%
344 RLJ ENTMT INC 200,000 774,000 0.02% Call
345 TRUPANION INC 88,020 748,000 0.02%
346 CVR REFNG LP 31,680 738,000 0.02%
347 ALDER BIOPHARMACEUTICALS INC 56,937 722,000 0.01%
348 AQUINOX PHARMACEUTICALS INC 105,646 704,000 0.01%
349 Gevo Inc 2,000,000 685,000 0.01% Call
350 GSV CAP CORP 67,254 673,000 0.01%
Page 7 of 8

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001164691-14-000207, filed 2014.11.14), New Holdings filing (0001164691-15-000179, filed 2015.11.19), New Holdings filing (0001164691-15-000140, filed 2015.08.17), New Holdings filing (0001164691-15-000101, filed 2015.05.21). and New Holdings filing (0001164691-15-000056, filed 2015.02.18).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.